PACS Interest Expense History
| PACS Stock | 33.63 -0.20 -0.59% |
Interest Expense | First Reported 2010-12-31 | Previous Quarter 28.36 million | Current Value 28.36 million | Quarterly Volatility 15.51 million |
Macro event markers
Latest PACS Interest Expense Growth Pattern
| Interest Expense | 10 Years Trend |
|
Interest Expense |
| Timeline |
Interest Expense Trend Statistics
Across 5 reporting periods, PACS's Interest Expense registers a CV of 107.5%, signaling wide dispersion driven primarily by directional growth rather than instability. The linear fit (R² = 0.55) suggests a moderate linear trend with partial explanatory power.| Arithmetic Mean | 14,426,681 | |
| Geometric Mean | 9,223,217 | |
| Coefficient Of Variation | 107.53 | |
| Mean Deviation | 12,915,785 | |
| Median | 5,278,000 | |
| Standard Deviation | 15,512,654 | |
| Sample Variance | 240.6T | |
| Range | 44.6M | |
| R-Value | 0.74 | |
| Mean Square Error | 116T | |
| R-Squared | 0.55 | |
| Significance | 0.0007 | |
| Slope | 2,274,624 | |
| Total Sum of Squares | 3850.3T |
PACS Interest Expense History
PACS has reported Interest Expense across 5 periods from 2022 to 2026, with values moving from 25.54 million to 33.76 million.Correlation of Interest Expense With Other Accounts
Cross-account correlations for PACS's Interest Expense measure how closely related line items have moved together historically. Correlation does not establish cause and effect.Click cells to compare fundamentals
Related Fundamentals
| Last Reported | End Of Year Estimate | ||
| Net Interest Income | $-28.36 million | $-29.78 million | |
| Minority Interest | $82,000 | $107,800 | |
| Interest Coverage | 10.92x | 9.38x | |
| Interest-Bearing Debt Per Share | 20.65 | 15.59 |
Methodology, Assumptions & Data Sources
This time-series chart captures PACS's Interest Expense over multiple fiscal years. The range between historical highs and lows defines the dispersion envelope across reported periods. For PACS as a Health Care Providers & Services company, Interest Expense is driven by the competitive and demand dynamics of its end markets.
Reported values for PACS Group are derived from periodic company reporting and market reference feeds and standardized for analysis. Reference data and historical patterns are presented and do not constitute an investment recommendation or advice.
Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board